Valneva SE (LTS:0OB3) Accounts Payable : €42.9 Mil (As of Sep. 2024)

View and export this data going back to 2011. Start your Free Trial

What is Valneva SE Accounts Payable?

Valneva SE's Accounts Payable for the quarter that ended in Sep. 2024 was €42.9 Mil.

Valneva SE's quarterly Accounts Payable declined from Mar. 2024 (€33.5 Mil) to Jun. 2024 (€8.5 Mil) but then increased from Jun. 2024 (€8.5 Mil) to Sep. 2024 (€42.9 Mil).

Valneva SE's annual Accounts Payable declined from Dec. 2021 (€16.0 Mil) to Dec. 2022 (€14.5 Mil) but then increased from Dec. 2022 (€14.5 Mil) to Dec. 2023 (€17.6 Mil).

Valneva SE Accounts Payable Historical Data

The historical data trend for Valneva SE's Accounts Payable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Valneva SE Accounts Payable Chart

Valneva SE Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Accounts Payable

Get a 7-Day Free Trial

8.87

24.90

16.04

14.51

17.56

Valneva SE Quarterly Data
	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24
Accounts Payable	Get a 7-Day Free Trial															94.24	17.56	33.51	8.53	42.90

Valneva SE Accounts Payable Calculation

Accounts Payable represents any money that a company owes its suppliers for goods and services purchased on credit and is expected to pay within the next year or operating cycle.

Valneva SE Accounts Payable Related Terms

Thank you for viewing the detailed overview of Valneva SE's Accounts Payable provided by GuruFocus.com. Please click on the following links to see related term pages.

Valneva SE Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Valneva SE (LTS:0OB3) » Definitions » Accounts Payable

Comparable Companies

Traded in Other Exchanges

VALN:USA INRLF:USA VLA:France AYJ:Germany AYJ0:Germany AYJ0:Germany AYJ:Germany AYJ:Germany AYJ:Germany VLA:Austria

Address

6 Rue Alain Bombard, Saint-Herblain, FRA, 44800

Website

https://www.valneva.com

Valneva SE is a vaccine company focused on developing life-saving vaccines. Its portfolio includes three vaccines for travelers. The segments of the group are Commercialized vaccines which relate to marketed vaccines, the group's vaccines IXIARO/JESPECT, DUKORAL, IXCHIQ; Covid includes development, manufacturing, & distribution related to the COVID-19 vaccine, Vaccine candidates which relate to research and development programs to generate new approvable products to generate future cash flows from product sales through partnering with pharmaceutical companies; & Technologies and services which relate to services and inventions at a commercialization stage. The company generates the majority of its revenue from product sales.

Valneva SE Headlines

No Headlines